REVISED: Clarification Regarding Fine Needle Aspiration (FNA) Specimen Adequacy Assessment, Rapid On-site Evaluation (ROSE) and Workload Limits
Published: 11/20/2026
Sources:
- Clinical Laboratory Improvement Amendments (CLIA),
- Centers for Medicare and Medicaid Services (CMS)
Relevant To:
- Critical Access Hospitals,
- Hospitals
The Centers for Medicare & Medicaid Services (CMS) has provided clarification related to FNA and ROSE under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).
A slide assessment that provides only a determination of specimen adequacy is not considered to be a slide examination for purposes of determining workload limits in accordance with 42 CFR 493.1274(d).
Per CMS:
- During a Fine Needle Aspiration (FNA) procedure, material is aspirated from a suspicious site, and then an adequa…